Envestnet Asset Management
INSM icon

Envestnet Asset Management’s Insmed INSM Stock Holding History

Envestnet Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.9M Buy
336,997
+37,072
+12% +$4.49M 0.01% 1052
2026
Q1 		$49M Buy
299,925
+23,820
+9% +$3.66M 0.01% 813
2025
Q4 		$48.1M Sell
276,105
-66,680
-19% -$12.2M 0.01% 765
2025
Q3 		$49.4M Sell
342,785
-23,042
-6% -$2.82M 0.01% 776
2025
Q2 		$36.8M Buy
365,827
+40,520
+12% +$3.1M 0.01% 895
2025
Q1 		$24.8M Buy
325,307
+68,949
+27% +$5.27M 0.01% 1063
2024
Q4 		$17.7M Buy
256,358
+15,227
+6% +$1.1M 0.01% 1270
2024
Q3 		$17.6M Buy
241,131
+65,667
+37% +$4.85M 0.01% 1263
2024
Q2 		$11.8M Buy
175,464
+119,214
+212% +$4.62M ﹤0.01% 1449
2024
Q1 		$1.53M Sell
56,250
-5,655
-9% -$158K ﹤0.01% 2750
2023
Q4 		$1.92M Buy
61,905
+1,923
+3% +$49.9K ﹤0.01% 2502
2023
Q3 		$1.51M Buy
59,982
+13,389
+29% +$306K ﹤0.01% 2523
2023
Q2 		$983K Buy
46,593
+127
+0.3% +$2.41K ﹤0.01% 2763
2023
Q1 		$792K Buy
46,466
+9,577
+26% +$186K ﹤0.01% 2834
2022
Q4 		$737K Sell
36,889
-3,645
-9% -$70.5K ﹤0.01% 2859
2022
Q3 		$873K Buy
40,534
+2,909
+8% +$69.7K ﹤0.01% 2679
2022
Q2 		$742K Buy
37,625
+4,849
+15% +$102K ﹤0.01% 2816
2022
Q1 		$770K Buy
32,776
+3,336
+11% +$77.5K ﹤0.01% 2851
2021
Q4 		$802K Buy
29,440
+5,736
+24% +$164K ﹤0.01% 2775
2021
Q3 		$653K Buy
23,704
+1,759
+8% +$46.1K ﹤0.01% 2806
2021
Q2 		$625K Sell
21,945
-1,881
-8% -$55.8K ﹤0.01% 2833
2021
Q1 		$812K Buy
23,826
+2,214
+10% +$84.6K ﹤0.01% 2555
2020
Q4 		$719K Buy
21,612
+1,032
+5% +$37.7K ﹤0.01% 2463
2020
Q3 		$661K Buy
20,580
+5,383
+35% +$155K ﹤0.01% 2319
2020
Q2 		$419K Buy
15,197
+844
+6% +$20K ﹤0.01% 2509
2020
Q1 		$230K Buy
+14,353
New +$340K ﹤0.01% 2673

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Envestnet Asset Management's INSM Position: Q2 2026 in Review

Envestnet Asset Management increased its Insmed (INSM) stake by 12% in Q2 2026, buying an estimated $4.49M and bringing the position to 336,997 shares worth $35.9M. The position accounts for 0.01% of the portfolio, ranked #1052.

Envestnet Asset Management first reported a position in INSM in Q1 2020 and has held it in 26 quarters since. The position peaked at $49.4M in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Envestnet Asset Management held 336,997 shares of Insmed worth $35.9M as of Q2 2026.
  • Envestnet Asset Management bought 37,072 Insmed shares in Q2 2026, an estimated $4.49M.
  • Insmed made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1052 holding.
  • Envestnet Asset Management first reported a position in Insmed in Q1 2020 and has held it in 26 quarters since.
  • Envestnet Asset Management's Insmed position peaked at $49.4M in Q3 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.